Zofran side effects – Blog Archive

GlaxoSmithKline Seeks Consolidation of Zofran Lawsuits in Federal Court

scolellawalsh on July 28, 2015

Category: Defective Drugs, Zofran
Tag: GlaxoSmithKline, ondansetron, Zofran, Zofran Birth Defects, Zofran Injuries, Zofran side effects

Zofran (ondansetron), manufactured by GlaxoSmithKline (GSK), is a member of a class of drugs known as 5-HT3 receptor antagonists, which work by blocking the actions of serotonin. Zofran is commonly prescribed for use by pregnant women suffering from morning sickness. Studies show that Zofran use by pregnant women can lead to a heightened risk of severe birth defects, including heart development irregularities, cleft lip and cleft palate.

On July 6, 2015, GSK filed a motion with the Judicial Panel on Multidistrict Litigation requesting the court to consolidate all Zofran cases before one judge into a Multi-District Litigation (MDL). Granting MDL treatment consolidates all federal lawsuits filed across the United States into one centralized district. This consolidation streamlines the pretrial discovery process, allowing the parties to avoid duplicative discovery and inconsistent rulings from different judges.

GSK argues that the United States District Court for the Eastern District of Pennsylvania, located in Philadelphia, PA, is the most convenient venue for the MDL.

If you or your child has suffered any injury as a result of taking Zofran, you can contact Stark & Stark and speak to one of the Mass Tort/Pharmaceutical Litigation attorneys, free of charge, who can help assess any claims that you might have against the Zofran manufacturers.

Zofran Studies Link Medication to Serious Health Risks

sstark on June 9, 2015

Category: Defective Drugs, Zofran
Tag: Zofran, Zofran Birth Defects, Zofran Injuries, Zofran Palate, Zofran side effects

A recent study by researchers at Harvard and Boston University’s Slone Epidemiology Center show that women exposed to Zofran, or a generic form of ondansetron, were 2.37 times more likely to deliver a baby with a cleft palate. These findings follow a series of epidemiological studies that have found an increased risk of major birth defects associated with exposure to Zofran during early pregnancy. For example, Swedish researchers, analyzing birth records from 1998 through 2012, concluded that “mothers who took Zofran during early pregnancy had a 62% increased risk of having a baby with a cardiovascular defect.”

Zofran Injuries Continue To Be Reported

mschrama on February 27, 2015

Category: Zofran
Tag: nausea and vomiting, ondansetron, pregnancy, Zofran, Zofran Birth Defects, Zofran Injuries, Zofran Palate, Zofran side effects

Zofran (ondansetron), manufactured by GlaxoSmithKline, is a member of a class of drugs known as 5-HT3 receptor antagonists, which work by blocking the actions of serotonin. Zofran was approved by the Food and Drug Administration (FDA) in January 1991, to treat chemotherapy-related nausea, and the approval was later expanded to treat postoperative nausea and vomiting.

According to recent allegations, it is believed that Zofran has also been marketed and prescribed for off-label uses, such as use by pregnant women suffering from morning sickness. According to a recent article published by the American Journal of Obstetrics & Gynecology, “Presently 97.7% of prescriptions for the treatment of nausea and vomiting in pregnancy in the United States are with medications not labeled for use in pregnancy, not indicated for nausea and vomiting in pregnancy, and not classified as safe in pregnancy by the Food and Drug Administration.”

Studies show that Zofran use by pregnant women can lead to a heightened risk of severe birth defects, including heart development irregularities, cleft lip and cleft palate.

If you feel you have experienced any side-effects from taking Zofran, you can contact Stark & Stark and speak to one of the Mass Tort/Pharmaceutical Litigation attorneys, free of charge, who can help assess any claims that you might have against the Zofran manufacturers.

Tag: Zofran side effects

GlaxoSmithKline Seeks Consolidation of Zofran Lawsuits in Federal Court

Zofran Studies Link Medication to Serious Health Risks

Zofran Injuries Continue To Be Reported

Blog Categories